| Literature DB >> 26992049 |
S M DeMonaco1, D C Grant1, M M Larson1, D L Panciera1, M S Leib1.
Abstract
BACKGROUND: Biliary sludge is associated with gallbladder (GB) dysmotility and mucus hypersecretion suggesting a link between biliary sludge and the formation of GB mucoceles (GBM). If biliary sludge progresses to GBM, treatment to reduce the production and progression of sludge is warranted. HYPOTHESIS/Entities:
Keywords: Gallbladder; Microlithiasis; Mucocele; Ultrasonography
Mesh:
Year: 2016 PMID: 26992049 PMCID: PMC4913576 DOI: 10.1111/jvim.13929
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Figure 1Representative ultrasound images of the gallbladder (GB) in dogs with (A) absence of biliary sludge—score 0, (B) mild biliary sludge—score 1, (C) moderate biliary sludge—score 2, (D) moderate to severe biliary sludge—score 3, (E) severe biliary sludge—score 4.
Figure 2Representative ultrasound images of the gallbladder (GB) in dogs with (A) dependent biliary sludge only—GB content 0, (B) dependent and nondependent sludge—GB content 1, (C) nondependent sludge only—GB content 2, (D), dependent and suspended sludge—GB content 3, (E), suspended sludge only—GB content 4, and (F) suspended, dependent, and nondependent sludge—GB content 5.
Summary of laboratory and GB variables in dogs with biliary sludge over time
| Variable | 0 Month (n = 42) | 3 Month (n = 42) | 6 Month (n = 42) | 9 Month (n = 41) | 12 Month (n = 38) |
|
|---|---|---|---|---|---|---|
| ALT (U/L) | 38 (14–450) | 40 (14–367) | 36 (16–141) | 42 (15–172) | 41.5 (17–131) | .14 |
| ALP (U/L) | 29 (6–225) | 30.5 (7–215) | 30 (6–164) | 30 (9–348) | 27 (11–103) | .58 |
| GGT (U/L) | 3.5 (0–18) | 3 (0–11) | 3 (0–8) | 3 (0–12) | 3 (0–7) | .48 |
| Tbili (mg/dL) | 0.2 (0.1–0.5)a,b,c | 0.2 (0.1–0.5) | 0.2 (0.1–0.4)a | 0.2 (0.1–0.4)b | 0.2 (0.1–0.3)c | .0026 |
| Trig (mg/dL) | 46 (24–493) | 52 (24–84) | 51 (30–135) | 53 (33–101) | 53.5 (23–170) | .15 |
| Chol (mg/dL) | 207 (±53) | 207 (±54) | 209 (±52) | 204 (±48) | 208 (±53) | .70 |
| tCa (mg/dL) | 9.7 (±0.5) | 9.7 (±0.4) | 9.8 (±0.5) | 9.7 (±0.4) | 9.8 (±0.2) | .055 |
| Alb (g/dL) | 3.3 (2.1–3.7)a,b | 3.2 (2.2–3.7)a | 3.25 (2.3–3.8) | 3.2 (2.2–3.7)b | 3.2 (2.1–3.7) | .0055 |
| Rel sludge (%) | 27 (±20) | 28 (±18) | 29 (±20) | 30 (±17) | 33 (±21) | .45 |
| Deg sludge | 1.5 (1–4) | 1 (0–4) | 1 (0–4) | 2 (0–4) | 2 (0–4) | .36 |
| GBV (mL/kg) | 1.03 (±0.59) | 1.22 (±0.74) | 1.19 (±0.70) | 1.18 (±0.88) | 1.20 (±0.73) | .19 |
| GBV (mL) | 17.0 (± 12.2) | 18.7 (±12.2) | 18.7 (± 13.7) | 17.4 (±13.8) | 16.3 (±11.2) | .54 |
| GBW (mm) | 1 (0.44–1.53)a,b | 1 (0.66–1.62) | 1 (0.92–2.89)a | 1 (0.94–1.97)b | 1 (0.90–1.35) | .015 |
ALT, alkaline aminotransferase; ALP, alkaline phosphatase; GGT, gamma‐glutamyl transferase; Tbili, total bilirubin; Trig, triglycerides; Chol, cholesterol; tCa, total calcium; Alb, albumin; Rel, relative sludge; Deg, degree of sludge; GBV/kg, gallbladder volume per kilogram; GB, gallbladder volume; GBW, gallbladder wall.
*Median (range), **Mean (standard deviation), n = number, P < .05 denotes statistical significance, significant differences are denoted by different superscript letters within columns.
Prevalence of heart murmurs, liver abnormalities, and medication exposure in dogs with or without increased biliary sludge
| Variable | Increased Sludge (n = 12) | Other (n = 30) |
|
|---|---|---|---|
| Heart murmur | 2 (17) | 5 (17) | 1.00 |
| Liver abnormalities | 1 (8) | 3 (10) | 1.00 |
| Systemic medications | 3 (25) | 7 (23) | 1.00 |
| Flea/tick | 8 (67) | 26 (86) | .20 |
| Heartworm | 10 (83) | 28 (93) | .56 |
| Ivermectin | 8 (67) | 9 (30) | .04 |
| Imidacloprid | 4 (33) | 6 (20) | .43 |
| Milbemycin oxime | 3 (25) | 12 (40) | .48 |
| Selamectin | 1 (8) | 6 (20) | .65 |
| Fipronil | 1 (8) | 8 (26) | .25 |
| Lufenuron | 2 (17) | 4 (13) | 1.00 |
| Spinosad | 1 (8) | 9 (30) | .23 |
| Antibiotics | 2 (17) | 6 (20) | 1.00 |
| NSAIDs | 1 (8) | 3 (10) | 1.00 |
| Prednisone | 1 (8) | 2 (7) | 1.00 |
n = number; number (%); increased sludge—dogs with increased degree of biliary sludge; other—dogs with decreased, static, recurrent, or resolved biliary sludge; NSAIDs—nonsteroidal anti‐inflammatories. P < 0.05 denotes statistical significance.
Association of biochemical indices and gallbladder measurements with spontaneous course of biliary sludge in dogs
| Variable | Static (n = 17) | Increased (n = 12) | Decreased (n = 8) | Recurrent (n = 4) |
|
|---|---|---|---|---|---|
| ALT (U/L) | 47 (15–141) | 40 (27–112) | 46 (20–131) | 29 (26–54) | .36 |
| ALP (U/L) | 21 (11–100) | 29 (13–107) | 29 (17–103) | 26 (14–78) | .78 |
| GGT (U/L) | 4 (2–6) | 2.5 (0–6) | 4 (2–7) | 3 (2–3) | .55 |
| Chol (mg/dL) | 216 (135–359) | 167 (144–266) | 202 (167–263) | 202 (156–223) | .38 |
| Trig (mg/dL) | 53 (35–101) | 48 (31–170) | 76 (23–107) | 58 (35–71) | .47 |
| Tbili (mg/dL) | 0.2 (0.2–0.3) | 0.2 (0.1–0.3) | 0.2 (0.2–0.3) | 0.2 (0.2–0.3) | .16 |
| tCa (mg/dL) | 9.9a (9.3–10.6) | 9.5a,b (9.2–10.2) | 10.2b (9.6–10.8) | 9.9 (9.4–10.0) | .024 |
| Alb (g/dL) | 3.3 (2.1—3.7) | 3.0 (2.2–3.5) | 3.3 (3.1–3.7) | 3.3 (3.1–3.5) | .12 |
| GBV (mL) | 15 (5.4–59) | 9.7 (3.4–30) | 14.5 (5.5–59.7) | 14.1 (7.5–21.6) | .38 |
| GBW (mm) | 1 (0.9–1.9) | 1 (0.9–1.1) | 1 (1–1.2) | 1 (1–1.5) | .39 |
ALT, alkaline aminotransferase; ALP, alkaline phosphatase; GGT, gamma‐glutamyl transferase; Tbili, total bilirubin; Trig, triglycerides; Chol, cholesterol; tCa, total calcium; Alb, albumin; GBV, gallbladder volume; GBW, gallbladder wall.
Median (range), n = number; P < .05 denotes statistical significance; significant differences are denoted by different superscript letters within columns. Determination of static, increased, decreased, and recurrent sludge is based on changes in degree of biliary sludge by comparing the degree of sludge at initial examination to the available last examination. The 1 dog with resolved biliary sludge was excluded from analysis.